BOSTON BIOPHARMA Trademark

Trademark Overview

On Tuesday, December 31, 2013, a trademark application was filed for BOSTON BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the BOSTON BIOPHARMA trademark a serial number of 86155475. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 7, 2021. This trademark is owned by Boston Biopharma, Inc. The BOSTON BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Consultation in the field of pharmaceutical research and development
boston biopharma

General Information

Serial Number86155475
Word MarkBOSTON BIOPHARMA
Filing DateTuesday, December 31, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 7, 2021
Registration Number4615430
Registration DateTuesday, September 30, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesPharmaceutical research and development; Consultation in the field of pharmaceutical research and development
Pseudo MarkBOSTON BIO PHARMA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 7, 2021
Primary Code042
First Use Anywhere DateMonday, December 24, 2012
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameBOSTON BIOPHARMA HOLDING, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressALPHARETTA, GA 30009
Party NameBoston Biopharma, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009
Party NameBoston Biopharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, DE 19711

Trademark Events

Event DateEvent Description
Friday, May 7, 2021CANCELLED SEC. 8 (6-YR)
Monday, September 30, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 14, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 15, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 15, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 30, 2014REGISTERED-SUPPLEMENTAL REGISTER
Thursday, August 28, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 20, 2014ASSIGNED TO LIE
Monday, August 11, 2014APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, August 11, 2014EXAMINER'S AMENDMENT ENTERED
Monday, August 11, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 11, 2014EXAMINERS AMENDMENT E-MAILED
Monday, August 11, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, July 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 16, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 16, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 16, 2014LETTER OF SUSPENSION E-MAILED
Monday, June 16, 2014SUSPENSION LETTER WRITTEN
Saturday, June 14, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 13, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 13, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 8, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 8, 2014NON-FINAL ACTION E-MAILED
Tuesday, April 8, 2014NON-FINAL ACTION WRITTEN
Wednesday, April 2, 2014ASSIGNED TO EXAMINER
Thursday, January 16, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, January 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

biopharma boston pharmaceutical development research field consultation